Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)
Author:
Funder
Eli Lilly and Company
Publisher
Springer Science and Business Media LLC
Subject
Dermatology
Link
https://link.springer.com/content/pdf/10.1007/s13555-023-01086-9.pdf
Reference27 articles.
1. Curmin R, Guillo S, De Rycke Y, et al. Switches between biologics in patients with moderate-to-severe psoriasis: results from the French cohort PSOBIOTEQ. J Eur Acad Dermatol Venereol. 2022;36:2101–12.
2. Dave R, Alkeswani A. An overview of biologics for psoriasis. J Drugs Dermatol. 2021;20:1246–7.
3. Augustin M, Schuster C, Mert C, et al. The value of indirect comparisons of systemic biologics for psoriasis: interpretation of efficacy findings. Dermatol Ther (Heidelb). 2022;12:1711–27.
4. Nast A, Dressler C, Schuster C, et al. Methods used for indirect comparisons of systemic treatments for psoriasis. A systematic review. Skin Health Dis. 2023;3:e112.
5. Lynde C, Riedl E, Maul J-T, et al. Comparative effectiveness of biologics across subgroups of patients with moderate-to-severe plaque psoriasis: results at week 12 from the PSoHO study in a real-world setting. Adv Ther. 2023;40(3):869–86.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Treatment-emergent Candida infections in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis treated with ixekizumab: an integrated safety analysis of 25 clinical studies;Expert Opinion on Drug Safety;2024-09-12
2. Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO);Acta Dermato-Venereologica;2024-09-05
3. Retention Rate of Ixekizumab in Psoriatic Arthritis: A Real-World Study;Journal of Personalized Medicine;2024-07-03
4. Disease severity in moderate‐to‐severe plaque psoriasis: Results from the Belgian REDISCOVER study;JEADV Clinical Practice;2024-07-02
5. Correction to: Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO);Dermatology and Therapy;2024-05-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3